Rapid Micro Biosystems (RPID) EPS (Weighted Average and Diluted) (2020 - 2026)

Rapid Micro Biosystems has disclosed EPS (Weighted Average and Diluted) across 7 years of filings, most recently posting -$0.31 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.31, down 19.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.11 (down 7.77% YoY), and the FY2025 annual result was -$1.05, up 2.78% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.31 for Q1 2026 at Rapid Micro Biosystems, down from -$0.27 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.22 in Q4 2024 to a low of -$0.38 in Q3 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.31 (2022), against an average of -$0.3.
• Peak annual rise in EPS (Weighted Average and Diluted) reached 99.08% in 2022, while the deepest fall reached 131.67% in 2022.
• Rapid Micro Biosystems' EPS (Weighted Average and Diluted) stood at -$0.38 in 2022, then surged by 31.58% to -$0.26 in 2023, then gained by 15.38% to -$0.22 in 2024, then slipped by 22.73% to -$0.27 in 2025, then dropped by 14.81% to -$0.31 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.31 (Q1 2026), -$0.27 (Q4 2025), and -$0.26 (Q3 2025), per Business Quant data.